 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 August 1996 | Volume 125 Issue 4 | Pages 257-264
Background: The acute clinical events surrounding the acquisition of human immunodeficiency virus (HIV) have not been well characterized.
Objective: To further define the clinical and epidemiologic presentation of primary HIV infection.
Design: Descriptive cohort study.
Setting: University research clinic.
Patients: 46 adults (43 men and 3 women) with primary HIV infection who enrolled in the study a median of 51 days after HIV seroconversion.
Measurements: Documentation of recent HIV seroconversion. Standardized collection of demographic characteristics and sexual contact history, results of tests for HIV RNA, HIV culture, and T-cell subsets.
Results: 41 of 46 patients (89%) developed an acute retroviral syndrome. Primary HIV infection was infrequently diagnosed at the initial medical encounter, even in persons enrolled in routine HIV screening programs. Median numbers of sexual partners 6 months and 1 month before acquisition of HIV were three and one, respectively; 21 patients (46%) reported having had only one partner in the month before seroconversion. Of the 12 patients who could identify the precise date of and activity leading to seroconversion, 4 reported having only oral-genital contact.
Conclusions: Primary HIV infection causes a recognizable clinical syndrome that is often underdiagnosed, even in persons enrolled in a program of routine surveillance for HIV infection. Frequency of sexual contact and overall numbers of sexual partners in this group of homosexual men who acquired HIV were markedly lower than those seen a decade ago. Acquisition of HIV does occur, even in persons with relatively few sexual partners. Increased attention to oral-genital contact as a means of acquiring HIV appears to be warranted.
Author and Article Information
From the University of Washington, Seattle, Washington.
ARTICLE
Clinical and Epidemiologic Features of Primary HIV Infection
Grant Support: In part by National Institutes of Health grants AI-45206 and AI-27757.
Requests for Reprints: Lawrence Corey, MD, Virology Division, University of Washington, Room 9301, 1200 12th Avenue South, Seattle, WA 98144.
Current Author Addresses: Drs. Shacker, Hughes, and Corey: Virology Division, University of Washington, Room 9301, 1200 12th Avenue South, Seattle, WA 98144.
This article has been cited by other articles:
|
|
 |
|
  N. Gasper-Smith, D. M. Crossman, J. F. Whitesides, N. Mensali, J. S. Ottinger, S. G. Plonk, M. A. Moody, G. Ferrari, K. J. Weinhold, S. E. Miller, et al. Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design J. Virol., August 1, 2008; 82(15): 7700 - 7710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Salazar-Gonzalez, E. Bailes, K. T. Pham, M. G. Salazar, M. B. Guffey, B. F. Keele, C. A. Derdeyn, P. Farmer, E. Hunter, S. Allen, et al. Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing J. Virol., April 15, 2008; 82(8): 3952 - 3970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Sudarshi, D Pao, G Murphy, J Parry, G Dean, and M Fisher Missed opportunities for diagnosing primary HIV infection Sex. Transm. Inf., February 1, 2008; 84(1): 14 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cao, J. McNevin, M. McSweyn, Y. Liu, J. I. Mullins, and M. J. McElrath Novel Cytotoxic T-Lymphocyte Escape Mutation by a Three-Amino-Acid Insertion in the Human Immunodeficiency Virus Type 1 p6Pol and p6Gag Late Domain Associated with Drug Resistance J. Virol., January 1, 2008; 82(1): 495 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Cantey, M. Goldblatt, G. M. Johnson, and J. R. Roberts A Flu-Like Illness Clinical Pediatrics, July 1, 2007; 46(6): 560 - 562. [PDF]
|
|
|
|
|
|
J. M. Milush, K. Stefano-Cole, K. Schmidt, A. Durudas, I. Pandrea, and D. L. Sodora Mucosal Innate Immune Response Associated with a Timely Humoral Immune Response and Slower Disease Progression after Oral Transmission of Simian Immunodeficiency Virus to Rhesus Macaques J. Virol., June 15, 2007; 81(12): 6175 - 6186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Umgelter, W Huber, R M Schmid, and W Reindl Coma as a presenting symptom of primary HIV infection Sex. Transm. Inf., April 1, 2007; 83(2): 85 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Llewellyn, R. Zioni, H. Zhu, T. Andrus, Y. Xu, L. Corey, and T. Zhu Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J. Leukoc. Biol., November 1, 2006; 80(5): 1118 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Horton, C. Havenar-Daughton, D. Lee, E. Moore, J. Cao, J. McNevin, T. Andrus, H. Zhu, A. Rubin, T. Zhu, et al. Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection J. Virol., October 1, 2006; 80(19): 9779 - 9788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xie, N. I. Belogortseva, J. Wu, W.-H. Lai, and C.-h. Chen Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Binding Domain of Porphyromonas gingivalis Gingipain. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3070 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Miyake, K. Ibuki, Y. Enose, H. Suzuki, R. Horiuchi, M. Motohara, N. Saito, T. Nakasone, M. Honda, T. Watanabe, et al. Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1311 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Speelmon, D. Livingston-Rosanoff, S. S. Li, Q. Vu, J. Bui, D. E. Geraghty, L. P. Zhao, and M. J. McElrath Genetic Association of the Antiviral Restriction Factor TRIM5{alpha} with Human Immunodeficiency Virus Type 1 Infection J. Virol., March 1, 2006; 80(5): 2463 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Grant, D. J. Jamieson, L. D. Elam-Evans, C. Beck-Sague, A. Duerr, and S. L. Henderson Reasons for Testing and Clinical and Demographic Profile of Adolescents With Non-Perinatally Acquired HIV Infection Pediatrics, March 1, 2006; 117(3): e468 - e475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Herbeck, D. C. Nickle, G. H. Learn, G. S. Gottlieb, M. E. Curlin, L. Heath, and J. I. Mullins Human Immunodeficiency Virus Type 1 env Evolves toward Ancestral States upon Transmission to a New Host J. Virol., February 15, 2006; 80(4): 1637 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hladik, H. Liu, E. Speelmon, D. Livingston-Rosanoff, S. Wilson, P. Sakchalathorn, Y. Hwangbo, B. Greene, T. Zhu, and M. J. McElrath Combined Effect of CCR5-{Delta}32 Heterozygosity and the CCR5 Promoter Polymorphism -2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission J. Virol., September 15, 2005; 79(18): 11677 - 11684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Coco The Cost-Effectiveness of Expanded Testing for Primary HIV Infection Ann. Fam. Med, September 1, 2005; 3(5): 391 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Coco and E. Kleinhans Prevalence of Primary HIV Infection in Symptomatic Ambulatory Patients Ann. Fam. Med, September 1, 2005; 3(5): 400 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Maher, Z.-Q. Zhang, T. W. Schacker, and P. J. Southern Ex Vivo Modeling of Oral HIV Transmission in Human Palatine Tonsil J. Histochem. Cytochem., May 1, 2005; 53(5): 631 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Puchhammer-Stockl, B. Schmied, A. Rieger, M. Sarcletti, M. Geit, R. Zangerle, and H. Hofmann Low Proportion of Recent Human Immunodeficiency Virus (HIV) Infections among Newly Diagnosed Cases of HIV Infection as Shown by the Presence of HIV-Specific Antibodies of Low Avidity J. Clin. Microbiol., January 1, 2005; 43(1): 497 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ritola, C. D. Pilcher, S. A. Fiscus, N. G. Hoffman, J. A. E. Nelson, K. M. Kitrinos, C. B. Hicks, J. J. Eron Jr., and R. Swanstrom Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1 J. Virol., October 15, 2004; 78(20): 11208 - 11218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Fulcher, Y. Hwangbo, R. Zioni, D. Nickle, X. Lin, L. Heath, J. I. Mullins, L. Corey, and T. Zhu Compartmentalization of Human Immunodeficiency Virus Type 1 between Blood Monocytes and CD4+ T Cells during Infection J. Virol., August 1, 2004; 78(15): 7883 - 7893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Regoes, R. Antia, D. A. Garber, G. Silvestri, M. B. Feinberg, and S. I. Staprans Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection J. Virol., May 1, 2004; 78(9): 4866 - 4875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J Donovan, J. C Rublein, P. A Leone, and C. D Pilcher HIV Infection: Point-of-Care Testing Ann. Pharmacother., April 1, 2004; 38(4): 670 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Smith, G. Meng, J. F. Salazar-Gonzalez, and G. M. Shaw Macrophage HIV-1 infection and the gastrointestinal tract reservoir J. Leukoc. Biol., November 1, 2003; 74(5): 642 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cao, J. McNevin, U. Malhotra, and M. J. McElrath Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection J. Immunol., October 1, 2003; 171(7): 3837 - 3846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Weintrob, J. Giner, P. Menezes, E. Patrick, D. K. Benjamin Jr, J. Lennox, C. D. Pilcher, J. J. Eron, and C. B. Hicks Infrequent Diagnosis of Primary Human Immunodeficiency Virus Infection: Missed Opportunities in Acute Care Settings Arch Intern Med, September 22, 2003; 163(17): 2097 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hladik, A. Desbien, J. Lang, L. Wang, Y. Ding, S. Holte, A. Wilson, Y. Xu, M. Moerbe, S. Schmechel, et al. Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-{gamma}-Secreting T Cells J. Immunol., September 1, 2003; 171(5): 2671 - 2683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Alter, G. Hatzakis, C. M. Tsoukas, K. Pelley, D. Rouleau, R. LeBlanc, J.-G. Baril, H. Dion, E. Lefebvre, R. Thomas, et al. Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection J. Immunol., July 1, 2003; 171(1): 477 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cao, J. McNevin, S. Holte, L. Fink, L. Corey, and M. J. McElrath Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection J. Virol., June 15, 2003; 77(12): 6867 - 6878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Havens and Committee on Pediatric AIDS Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus Pediatrics, June 1, 2003; 111(6): 1475 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Learn, D. Muthui, S. J. Brodie, T. Zhu, K. Diem, J. I. Mullins, and L. Corey Virus Population Homogenization following Acute Human Immunodeficiency Virus Type 1 Infection J. Virol., October 25, 2002; 76(23): 11953 - 11959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dybul, A. S. Fauci, J. G. Bartlett, J. E. Kaplan, and A. K. Pau Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV Ann Intern Med, September 3, 2002; 137(5_Part_2): 381 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Pilcher, J. T. McPherson, P. A. Leone, M. Smurzynski, J. Owen-O'Dowd, A. L. Peace-Brewer, J. Harris, C. B. Hicks, J. J. Eron Jr, and S. A. Fiscus Real-time, Universal Screening for Acute HIV Infection in a Routine HIV Counseling and Testing Population JAMA, July 10, 2002; 288(2): 216 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Daar and S. Little Diagnosing Primary HIV Infection Ann Intern Med, March 19, 2002; 136(6): 488 - 489. [Full Text] [PDF]
|
|
|
|
 |
|
 A H Morris Decision support and safety of clinical environments Qual. Saf. Health Care, March 1, 2002; 11(1): 69 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yawetz and E. J. Mark Case 37-2001- A 76-Year-Old Man with Fever, Dyspnea, Pulmonary Infiltrates, Pleural Effusions, and Confusion N. Engl. J. Med., November 29, 2001; 345(22): 1627 - 1634. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Pilcher, J. J. Eron Jr, P. L. Vemazza, M. Battegay, T. Harr, S. Yerly, S. Vom, and L. Perrin Sexual Transmission During the Incubation Period of Primary HIV Infection JAMA, October 10, 2001; 286(14): 1713 - 1714. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Hansasuta and S. L Rowland-Jones HIV-1 transmission and acute HIV-1 infection Br. Med. Bull., September 1, 2001; 58(1): 109 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Wallace, J A Nelson, J A McCutchan, T Wolfson, and I Grant Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment Sex. Transm. Inf., June 1, 2001; 77(3): 199 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Daar, S. Little, J. Pitt, J. Santangelo, P. Ho, N. Harawa, P. Kerndt, J. V. Giorgi, J. Bai, P. Gaut, et al. Diagnosis of Primary HIV-1 Infection Ann Intern Med, January 2, 2001; 134(1): 25 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Flanigan and K. T. Tashima Diagnosis of Acute HIV Infection: It's Time To Get Moving! Ann Intern Med, January 2, 2001; 134(1): 75 - 77. [Full Text] [PDF]
|
|
|
|
 |
|
 Before Seroconversion: The Clinical and Scientific Events of Acute HIV Infection and the Immunologic Benefits of Treatment AIDS Clinical Care, January 1, 2001; 2001(101): 7 - 7. [Full Text]
|
|
|
|
|
|
R. Colven, R. D. Harrington, D. H. Spach, C. J. Cohen, and T. M. Hooton Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection Ann Intern Med, September 19, 2000; 133(6): 430 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Wahl, T. Greenwell-Wild, H. Hale-Donze, N. Moutsopoulos, and J. M. Orenstein Permissive factors for HIV-1 infection of macrophages J. Leukoc. Biol., September 1, 2000; 68(3): 303 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Brodie Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease J. Leukoc. Biol., September 1, 2000; 68(3): 351 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M Marra and J. Booss Does brain penetration of anti-HIV drugs matter? Sex. Transm. Inf., February 1, 2000; 76(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Keerasuntonpong, J. Pitt, P. L. Gaut, and E. S. Daar PRIMARY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION IN PREGNANCY Obstet. Gynecol., November 1, 1999; 94(5): 844 - 844. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Little, E. S. Daar, R. T. D'Aquila, P. H. Keiser, E. Connick, J. M. Whitcomb, N. S. Hellmann, C. J. Petropoulos, L. Sutton, J. A. Pitt, et al. Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection JAMA, September 22, 1999; 282(12): 1142 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stahl-Hennig, R. M. Steinman, K. Tenner-Racz, M. Pope, N. Stolte, K. Mätz-Rensing, G. Grobschupff, B. Raschdorff, G. Hunsmann, and P. Racz Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus Science, August 20, 1999; 285(5431): 1261 - 1265. [Abstract] [Full Text]
|
|
|
|
|
|
S. I. Staprans, P. J. Dailey, A. Rosenthal, C. Horton, R. M. Grant, N. Lerche, and M. B. Feinberg Simian Immunodeficiency Virus Disease Course Is Predicted by the Extent of Virus Replication during Primary Infection J. Virol., June 1, 1999; 73(6): 4829 - 4839. [Abstract] [Full Text]
|
|
|
|
|
|
E. S. Rosenberg, A. M. Caliendo, and B. D. Walker Acute HIV Infection among Patients Tested for Mononucleosis N. Engl. J. Med., March 25, 1999; 340(12): 969 - 969. [Full Text]
|
|
|
|
|
|
D. Velin, G. Fotopoulos, J.-P. Kraehenbuhl, and H. Acha-Orbea Systemic Antibodies Can Inhibit Mouse Mammary Tumor Virus-Driven Superantigen Response in Mucosa-Associated Lymphoid Tissues J. Virol., February 1, 1999; 73(2): 1729 - 1733. [Abstract] [Full Text]
|
|
|
|
|
|
J. O. Kahn and B. D. Walker Acute Human Immunodeficiency Virus Type 1 Infection N. Engl. J. Med., July 2, 1998; 339(1): 33 - 39. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Janssen, G. A. Satten, S. L. Stramer, B. D. Rawal, T. R. O'Brien, B. J. Weiblen, F. M. Hecht, N. Jack, F. R. Cleghorn, J. O. Kahn, et al. New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes JAMA, July 1, 1998; 280(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-A. Morandi, G. A. Schockmel, S. Yerly, P. Burgisser, P. Erb, L. Matter, R. Sitavanc, and L. Perrin Detection of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Pools of Sera Negative for Antibodies to HIV-1 and HIV-2 J. Clin. Microbiol., June 1, 1998; 36(6): 1534 - 1538. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M. Macher and E. P. Goosby Primary HIV Infection/Acute Retroviral Syndrome: An Intervention Opportunity for Correctional Facilities Journal of Correctional Health Care, April 1, 1998; 5(1): 51 - 62. [Abstract] [PDF]
|
|
|
|
 |
|
 J. A. Bartlett Strategies of Antiretroviral Therapy in Adults Oncologist, April 1, 1998; 3(2): 111 - 118. [Abstract] [Full Text]
|
|
|
|
|
|
Immunologic Response to HIV AIDS Clinical Care, January 1, 1998; 1998(101): 1 - 1. [Full Text]
|
|
|
|
|
|
L. Musey, J. Hughes, T. Schacker, T. Shea, L. Corey, and M. J. McElrath Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection N. Engl. J. Med., October 30, 1997; 337(18): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Velin, G. Fotopoulos, F. Luthi, and J.-P. Kraehenbuhl The Nasal-associated Lymphoid Tissue of Adult Mice Acts as an Entry Site for the Mouse Mammary Tumor Retrovirus J. Exp. Med., May 19, 1997; 185(10): 1871 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|
Article
